APPLICATION OF METHOD FOR ADMINISTRATION OF SODIUM SALT OF 2-METHYLTHIO-6-NITRO-1,2-4-TRIAZOL[5,1-C] -1,2,4-TRIAZIN-7-ONE, DIHYDRATE WITH ANTIVIRAL ACTIVITY, FOR TREATMENT OF CORONAVIRUS INFECTION COVID-19 Russian patent published in 2021 - IPC A61K31/708 A61P31/14 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to infectious diseases, and is intended for the treatment of coronavirus infection COVID-19. In treatment of the new coronavirus infection COVID-19, the method of administration of the sodium salt of 2-methylthio-6-nitro-1,2-4-triazol[5,1-c]-1,2,4-triazin-7-one, dihydrate, with antiviral activity, is used. Within five days capsules are taken containing 250 mg of sodium salt of 2-methylthio-6-nitro-1,2-4-triazol[5,1-c]-1,2,4-triazin-7-one, dihydrate, by taking one capsule of riamilovir, containing 250 mg of sodium salt of 2-methylthio-6-nitro-1,2-4-triazol[5,1-c]-1,2,4-triazin-7-one, dihydrate, five times a day with a total dosage of 1250 mg/day. Meanwhile, the time interval between doses of the drug is 3 hours.

EFFECT: invention provides treatment for coronavirus infection COVID-19.

1 cl, 5 tbl